BWX Technologies, Inc. BWXT
0 trading plans running, 6 Form 144 notices for $7.0M
10-Q, 10-K and Form 144What BWXT's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Aug 11, 2025 to Nov 16, 2026. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| Kevin McCoy Chief Nuclear Officer |
Adopted 10b5-1 plan | Aug 28, 2025 | 10-Q Nov 3, 2025 | ||
What the company wroteAugust 11, 2025, Rex Geveden, President and Chief Executive Officer and a director, entered into a trading plan (the "Geveden Plan") intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) and (ii) on August 28, 2025, Kevin McCoy, Chief Nuclear Officer, entered into a trading plan (the "McCoy Plan") intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The Geveden Plan provides for the sale of an aggregate of up to 40,000 shares of common stock of the Company and terminates on August 14, 2026, unless terminated sooner in accordance with its terms. The McCoy Plan provides for the sale of an aggregate of up to 9,986 shares of common stock of the Company and terminates on August 31, 2026, unless terminated sooner in accordance with its terms. | |||||
| Rex Geveden President and Chief Executive Officer |
Adopted 10b5-1 plan | Aug 11, 2025 | 10-Q Nov 3, 2025 | ||
What the company wroteAugust 11, 2025, Rex Geveden, President and Chief Executive Officer and a director, entered into a trading plan (the "Geveden Plan") intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) and (ii) on August 28, 2025, Kevin McCoy, Chief Nuclear Officer, entered into a trading plan (the "McCoy Plan") intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The Geveden Plan provides for the sale of an aggregate of up to 40,000 shares of common stock of the Company and terminates on August 14, 2026, unless terminated sooner in accordance with its terms. The McCoy Plan provides for the sale of an aggregate of up to 9,986 shares of common stock of the Company and terminates on August 31, 2026, unless terminated sooner in accordance with its terms. | |||||
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 17 filings checked since May 8, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Aug 12, 2026 | Geveden Rex D Officer, Director |
10,000 | $1.7M |
| May 12, 2026 | Geveden Rex D Officer, Director |
10,000 | $2.0M |
| May 11, 2026 | Fitzgerald Michael Thomas Officer |
2,417 | $506K |
| Mar 2, 2026 | Gorman Kevin James Officer |
1,344 | $289K |
| Feb 25, 2026 | Burbach Gerhard F Director |
1,983 | $414K |
| Feb 12, 2026 | Geveden Rex D Officer, Director |
10,000 | $2.0M |
From the Form 144 XML filed with the SEC, since Feb 12, 2026. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/BWXT/export.csv") into a cell.